MSP-2020 and MSP-2003, exhibiting a stronger and shorter acting psychedelic effect than psilocybin in preclinical testing, are selected for IND enabling...
The article News You Might Have Missed: Oct 3rd, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
To broaden the appeal of therapist-assisted psychedelics, a number of companies are engineering out the hallucinogenic aspect. The post Researchers Seek...
Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics™, is pleased to announce...
The article Cybin Buys License to Mindset Pharma’s Psychedelic Compounds was originally published on Microdose. Cybin Obtains Exclusive License to a...
Licensing Subset of Mindset’s Family 1 Intellectual Property Underscores Strength of Mindset’s Portfolio and Business StrategyTORONTO, Sept. 27, 2022...
People who stacked psilocybin with other substances like these were less likely to drink alcohol or smoke cigarettes as well. The post Psychedelic Stacking...
TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery...
Big money is starting to take a more public interest in the science of psychedelics, which makes even the biggest skeptics take notice. The post Big...
TORONTO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery...